| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > 7 Key Dimensions of High Performance Teams |
|
Just Other Articles - 7 Key Dimensions of High Performance Teams
7 Key Dimensions of High Performance Teams We can always look at the behaviors and skills of team leaders an According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d team members in analyzing team performance and success, but it is also instructive to look at the overall team as well. The l ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in st of attributes that follows describes team units that are highly productive and successful. You can use this list as a set of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. criteria by which you can judge your own team. Commitment - Team members see themselves belonging to the tea here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe . They are committed to group goals above and beyond their personal goals and agendas. Trust - Team members d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ave faith in each other to honor commitments, maintain confidences, support each other and generally behave predictably and cons ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc stently. Purpose - The team understands how it fits into the overall business of the organization. Team memb easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi rs know their roles, feel a sense of ownership, and can see how they personally, and as a team, make a difference. Co nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically munication – Effective teams communicate effectively and frequently with each other and also communicate clearly and co and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ sistently with people outside the team about team activities. Effective internal communication allows these teams to make balan ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ed decisions, handle conflict constructively and provide each other valuable feedback. Involvement - Every ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a one has a role on the team. Despite differences in roles, perspectives and experience, team members feel a sense of partnership dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ith each other. Contributions are respected and expected. True consensus is reached when appropriate. Process Orienta cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ion – High performing teams have a large number of process tools they can use when needed. Process tools would include: tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen problem solving tools, planning techniques, regular meetings, agendas, and successful ways of dealing with problems, behavioral t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel greements, and ways to improve those processes within the team. Continuous Improvement - The team understand ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the importance of continuous improvement, has the tools, knowledge and time at their disposal to make Continuous Improvement re y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products lly happen. All improvement efforts are done in support of the organization’s goals and objectives. If you feel a team is rea . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de y for such a discussion, pull out this list of attributes and have a team discussion on how well people feel their team is doing elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip on each of these dimensions, the discussion can be enlightening and help the team move its performance to even higher levels. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Every Employer Should Know When They Can No Longer Offer Health Insurance Coverage
|